We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
PUT
Zoetis
ZTS
$31.6B
| $265K | ﹤0.01% |
+1,600
| New | +$246K |
|
1902
KVH Industries
KVHI
$177M
| $264K | ﹤0.01% |
+29,319
| New | +$246K |
|
1903
TherapeuticsMD
TXMD
$23.8M
| $264K | ﹤0.01% |
3,343
-11,023
| -77% | -$879K |
|
1904
CALL
McDonald's
MCD
$188B
| $263K | ﹤0.01% |
+1,200
| New | +$246K |
|
|
1905
PUT
McDonald's
MCD
$188B
| $263K | ﹤0.01% |
+1,200
| New | +$246K |
|
1906
Minerals Technologies
MTX
$2.31B
| $263K | ﹤0.01% |
5,148
-16,750
| -76% | -$828K |
|
1907
News Corp Class B
NWS
$16.4B
| $263K | ﹤0.01% |
18,800
+4,701
| +33% | +$65.6K |
|
|
CFB
1908
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $263K | ﹤0.01% |
+30,224
| New | +$285K |
|
1909
eGain
EGAN
$176M
| $262K | ﹤0.01% |
18,482
+2,892
| +19% | +$33.7K |
|
1910
Installed Building Products
IBP
$6.13B
| $262K | ﹤0.01% |
2,577
-20,362
| -89% | -$1.75M |
|
1911
PJT Partners
PJT
$4.37B
| $262K | ﹤0.01% |
4,320
-6,479
| -60% | -$364K |
|
1912
Tonix Pharmaceuticals
TNXP
$157M
| – | – |
0
| – | – |
|
1913
Vodafone
VOD
$34.9B
| $262K | ﹤0.01% |
19,520
+8,163
| +72% | +$123K |
|
|
XHR
1914
Xenia Hotels & Resorts
XHR
$1.98B
| $262K | ﹤0.01% |
29,788
+1,476
| +5% | +$13K |
|
|
CEO
1915
DELISTED
CNOOC Limited
CEO
| $262K | ﹤0.01% |
+2,724
| New | +$300K |
|
|
STL
1916
DELISTED
Sterling Bancorp
STL
| $262K | ﹤0.01% |
24,943
+443
| +2% | +$5.02K |
|
1917
Cameco
CCJ
$38.3B
| $261K | ﹤0.01% |
+25,822
| New | +$280K |
|
1918
Envista
NVST
$4.28B
| $261K | ﹤0.01% |
+10,559
| New | +$243K |
|
1919
Pennant Group
PNTG
$1.43B
| $261K | ﹤0.01% |
+6,772
| New | +$208K |
|
|
LGTY
1920
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $261K | ﹤0.01% |
+18,555
| New | +$290K |
|
|
JNCE
1921
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $261K | ﹤0.01% |
+31,937
| New | +$198K |
|
1922
Barclays
BCS
$94.1B
| $260K | ﹤0.01% |
+51,996
| New | +$287K |
|
1923
CarGurus
CARG
$3.01B
| $260K | ﹤0.01% |
12,000
-46,228
| -79% | -$1.18M |
|
1924
Xencor
XNCR
$1.44B
| $260K | ﹤0.01% |
6,700
-45,430
| -87% | -$1.58M |
|
|
LEAP.U
1925
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
| $260K | ﹤0.01% |
+20,000
| New | +$255K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.